Radio-Onkologie Solothurn AG

Radio-Onkologie Solothurn AG (ROSOL) is a company owned by Solothurner Spitäler AG and Inselspital Bern. We jointly operate a linear accelerator. This special type of radiation therapy is suitable for the treatment of benign and malignant cancers.

All important information and contact details can be found on the Radio-Onkologie Solothurn website:

• Radio-Onkologie

Our range of services:

• Percutaneous therapy for brain, bronchial, breast, prostate, rectal, and esophageal carcinomas as well as malignant lymphomas
• Simultaneous radio-chemotherapy in collaboration with medical oncologists
• Symptom-oriented radiation of metastases
• Radiotherapy for benign lesions, such as tendinosis, arthrosis, ossification, and keloids
• Access to high-precision radiation and brachytherapy, as well as clinical trials at Inselspital

Further indications can be discussed with our physicians at any time.